Rheumatoid arthritis (RA) control and outcome has greatly improved with the efficacy of biologic disease-modifying antirheumatic drugs (DMARDs) combined with early effective management and treatment targeting remission or low disease activity.However, although biologic therapy-blocking key molecules involved...
Cyclosporine Tacrolimus DMARDs= disease-modifying antirheumatic drugs, SLE= systemic lupus erythematosus • Patients with organ transplants should be continued on immunosuppressant medications unless directed otherwise by transplant physician. Sirolimus (Rapamune) is associated with sign...